share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kearney Terrence C

SEC announcement ·  May 3 16:19
Summary by Moomoo AI
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Terrence C Kearney, a reporting person associated with the company. The transaction, which took place on 05/01/2024, did not specify Kearney's relationship to the issuer. Details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement.
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Terrence C Kearney, a reporting person associated with the company. The transaction, which took place on 05/01/2024, did not specify Kearney's relationship to the issuer. Details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more